A detailed history of Pictet Asset Management Sa transactions in Bei Gene, Ltd. stock. As of the latest transaction made, Pictet Asset Management Sa holds 125,054 shares of BGNE stock, worth $22.2 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
125,054
Previous 112,940 10.73%
Holding current value
$22.2 Million
Previous $24.3 Million 8.4%
% of portfolio
0.03%
Previous 0.03%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023

BUY
$178.3 - $266.78 $2.16 Million - $3.23 Million
12,114 Added 10.73%
125,054 $22.3 Million
Q1 2023

May 10, 2023

SELL
$215.53 - $274.5 $2.43 Million - $3.09 Million
-11,270 Reduced 9.07%
112,940 $24.3 Million
Q4 2022

Feb 13, 2023

SELL
$125.51 - $229.3 $19.1 Million - $34.9 Million
-152,208 Reduced 55.06%
124,210 $27.3 Million
Q3 2022

Nov 14, 2022

SELL
$131.8 - $202.24 $4.28 Million - $6.57 Million
-32,501 Reduced 10.52%
276,418 $37.3 Million
Q2 2022

Aug 09, 2022

BUY
$121.11 - $216.05 $28.1 Million - $50.1 Million
231,976 Added 301.49%
308,919 $50 Million
Q1 2022

May 13, 2022

SELL
$146.52 - $269.56 $19.4 Million - $35.7 Million
-132,558 Reduced 63.27%
76,943 $14.5 Million
Q4 2021

Feb 10, 2022

SELL
$248.56 - $389.34 $25.8 Million - $40.4 Million
-103,893 Reduced 33.15%
209,501 $56.8 Million
Q3 2021

Nov 12, 2021

BUY
$249.6 - $403.14 $78.2 Million - $126 Million
313,394 New
313,394 $8.9 Million

Others Institutions Holding BGNE

About BeiGene, Ltd.


  • Ticker BGNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 103,700,000
  • Market Cap $18.4B
  • Description
  • BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...
More about BGNE
Track This Portfolio

Track Pictet Asset Management Sa Portfolio

Follow Pictet Asset Management Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pictet Asset Management Sa, based on Form 13F filings with the SEC.

News

Stay updated on Pictet Asset Management Sa with notifications on news.